Shenzhen Kangtai Biological Products (300601.SZ): Four-strain influenza virus split vaccines obtained drug registration certificate.

Shenzhen Kangtai Biological Products (300601.SZ) announced that the company's quadrivalent influenza split virus vaccine has received the "Drug Registration Certificate" issued by the National Medical Products Administration today. The quadrivalent influenza split virus vaccine is suitable for individuals aged 3 and above, and can stimulate the body to produce immunity against influenza viruses, used to prevent epidemic influenza caused by vaccine-related strains.